• 1
  • 2

2-day GCP training for investigators in Moscow

Servicesof Asclepius CRO

Monitoring Read More
Data management Read More
Clinical trials in phases II-IV Read More
For patients: participation in clinical trials Read More

Fast

Qualified
 

Asclepius Ltd: enhanced patient recruitment and clinical data

Asclepius Ltd. was founded in 2006 in response to the ongoing growth of the clinical trials market in Russia. Asclepius Ltd. is an independent Contract Research Organization (CRO) dedicated to carrying out clinical trials in phases II-IV in Russia to the highest standards of GCP.
With our experience of the Russian market we are confident that we can match the potential advantages of trialing your drug here with the most professional working practices.
From our offices in Moscow and Saint Petersburg we are ready to see through the design, setup and conduct of clinical trials, particularly large Phase II - IV international programmes involving hundreds of patients throughout Russia.

Read More

  • 1

Articles Blog

  • Clinical Trials (F.A.Q.)

    1. What are clinical trials, and why are they important?

    Clinical trials are research studies conducted with people who volunteer to take part testing how well new medical approaches work. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose, or treat a disease.

    Read more...  
  • Growth: from quantity to quality (A review of the clinical trials market)

    The number of clinical trials in Russia has increased from just over 60 in 1998 to 260 today. Now that the clinical trials market is no longer in its infancy CROs increasingly need a new vision for their business that takes account of the longer term.
    The legacy of the Soviet period remains a highly centralized medical system that is well suited to the CRO market and an ongoing search for the best management methods and skills. The arrival of western CROs helped to introduce western corporate standards but in the uncertainty of Russia in the 1990s quality came second to short term expediency.

    Read more...